Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus)

Psychopharmacology

Volumn 166, Issue 3, 2003, Pages 212-220

  Muggleton, N G ^a,c   Bowditch, A P ^b   Crofts, H S ^a,d   Scott, E A M ^b   Pearce, P C ^b  

^a SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UK   (United Kingdom)

Author keywords

Discrimination; Marmoset; Organophosphate; Physostigmine; Pretreatment; Reversal; Sarin; Scopolamine; Soman

Indexed keywords

ORGANOPHOSPHATE; PHYSOSTIGMINE; SARIN; SCOPOLAMINE; SOMAN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL WARFARE; CHOLINERGIC RECEPTOR BLOCKING; CHOLINERGIC STIMULATION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; INTOXICATION; MALE; MARMOSET; NONHUMAN; PRIORITY JOURNAL; TASK PERFORMANCE;

EID: 0344643406     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1324-7     Document Type: Article

References (33)

1. Aigner TG, Mitchell SJ, Aggleton JP, DeLong MR, Struble RG, Price DL, Wenk GL, Mishkin M (1987) Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert. Psychopharmacology 92:292-300
2. Blokland A (1996) Acetylcholine: a neurotransmitter for learning and memory? Brain Res Rev 21:285-300
3. Carey GJ, Costall B, Domeney AM, Gerrard PA, Jones DN, Naylor RJ, Tyers MB (1992) Ondansetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset. Pharmacol Biochem Behav 42:75-83
4. Cotterman TE, Meyer DR, Wickens DD (1956) Discrimination reversal learning in marmosets. J Comp Physiol Psychol 49:539-541
5. Crofts HS (1998) Methodology for the repeated assessment of cognitive and physiological parameters within a home cage environment in the common marmoset (Callithrix jacchus): assessment of repeated attentional set shifting and the sleep electroencephalogram. Thesis, University of Bristol
6. Crofts HS, Muggleton NG, Pearce PC, Nutt DJ, Scott EAM (1995) A home-cage system for neuropsychological testing in non-human primates. J Psychopharmacol Suppl 9:A12
7. Crofts HS, Muggleton NG, Bowditch AP, Pearce PC, Nutt DJ, Scott EA (1999) Home cage presentation of complex discrimination tasks to marmosets and rhesus monkeys. Lab Anim 33:207-214
8. Dirnhuber P, French MC, Green DM, Leadbeater L, Stratton JA (1979) The protection of primates against soman poisoning by pretreatment with pyridostigmine. J Pharm Pharmacol 31:295-299
9. D'Mello GD, Duffy EA (1985) The acute toxicity of satin in marmosets (Callithrix jacchus): a behavioral analysis. Fundam Appl Toxicol 5:S169-S174
10. Fosbraey P, Wetherell JR, French MC (1990) Neurotransmitter changes in guinea-pig brain regions following soman intoxication. J Neurochem 54:72-79
11. Harder JA, Baker HF, Ridley RM (1998) The role of the central cholinergic projections in cognition: implications of the effects of scopolamine on discrimination learning by monkeys. Brain Res Bull 45:319-326
12. Harris LW, Talbot BG, Lennox WJ, Anderson DR, Solana RP (1991) Physostigmine (alone and together with adjunct) pretreatment against soman, satin, tabun and VX intoxication. Drug Chem Toxicol 14:265-281
13. Leadbeater L, Inns RH, Rylands JM (1985) Treatment of poisoning by soman. Fundam Appl Toxicol 5:S225-S231
14. Lennox WJ, Harris LW, Anderson DR, Solana RP, Murrow ML, Wade JV (1992) Successful pretreatment/therapy of soman, satin and VX intoxication. Drug Chem Toxicol 15:271-283
15. Mackintosh NJ (1962) The effects of overtraining on a reversal and non reversal shift. J Comp Physiol Psychol 55:555-559
16. Mirza NR, Stolerman IP (2000) The role of nicotinic and muscarinic acetylcholine receptors in attention. Psychopharmacology 148:243-250
17. Muir JL (1997) Acetylcholine, aging, and Alzheimer's disease. Pharmacol Biochem Behav 56:687-696
18. Pearce PC, Crofts HS, Muggleton NG, Scott EAM (1998) Concurrent monitoring of EEG and performance in the common marmoset: a methodological approach. Physiol Behav 63:591-599
19. Pearce PC, Crofts HS, Muggleton NG, Ridout D, Scott EAM (1999) The effects of acutely administered low dose satin on cognitive behaviour and the electroencephalogram in the common marmoset. J Psychopharmacol 13:121-128
20. Ridley RM, Bowes PM, Baker HF, Crow TJ (1984) An involvement of acetylcholine in object discrimination learning and memory in the marmoset. Neuropsychologia 22:253-263
21. Ridley RM, Baker HF, Drewett B, Johnson JA (1985) Effects of ibotenic acid lesions of the basal forebrain on serial reversal learning in marmosets. Psychopharmacology 86:438-443
22. Roberts AC, Robbins TW, Everitt BJ (1988) The effects of intradimensional and extradimensional shifts on visual discrimination learning in humans and non-human primates. Q J Exp Psychol B 40:321-341
23. Roberts AC, Robbins TW, Everitt BJ, Jones GH, Sirkia TE, Wilkinson J, Page K (1990) The effects of excitotoxic lesions of the basal forebrain on the acquisition, retention and serial reversal of visual discriminations in marmosets. Neuroscience 34:311-329
24. Roberts AC, Robbins TW, Everitt BJ, Muir JL (1992) A specific form of cognitive rigidity following excitotoxic lesions of the basal forebrain in marmosets. Neuroscience 47:251-264
25. Robbins TW, McAlonan G, Muir JL, Everitt BJ (1997) Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease. Behav Brain Res 83:15-23
26. Rusted JM, Warburton DM (1988) The effects of scopolamine on working memory in healthy young volunteers. Psychopharmacology 96:145-152
27. Sarter M (1994) Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin? Psychopharmacology 114:539-550
28. Scott EAM, Hollands RN, Wetherall JR (1994) The current UK medical countermeasures for nerve agent poisoning; physostigmine and hyoscine as an alternative to pyridostigmine. In: Proceedings of the CB Medical Treatment Symposium, AC-Laboratorium Spiez, Switzerland, pp 1.14-1.17
29. Taffe MA, Weed MR, Gold LH (1999) Scopolamine alters rhesus monkey performance on a novel neuropsychological test battery. Cogn Brain Res 8:203-212
30. von Bredow J, Corcoran K, Maitland G, Kaminskis A, Adams N, Wade J (1991) Efficacy evaluation of physostigmine and anticholinergic adjuncts as a pretreatment for nerve agent intoxication. Fundam Appl Toxicol 17:782-789
31. Warburton DM, Brown K (1972) The facilitation of discrimination performance by physostigmine sulphate. Psychopharmacologia 27:275-284
32. Wetherell A (1992) Effects of physostigmine on stimulus encoding in a memory-scanning task. Psychopharmacology 109:198-202
33. Wetherell JR (1994) Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning. J Pharm Pharmacol 46:1023-1028